Interspecies differences on pharmacokinetics of rebamipide following oral administration to rats and dogs. 2020

In-Hwan Baek, and Dong Kyoung Ha, and Da-Seul Joo, and Min Ji Kim
College of Pharmacy, Kyungsung University, Busan, Republic of Korea.

Rebamipide is used widely in East Asia for the treatment of gastric ulcers, acute gastritis, and exacerbated chronic gastritis. The objective of this study was to investigate the pharmacokinetic (PK) properties of rebamipide following single oral administration in rats and dogs. Eleven rats and dogs received single oral administrations of rebamipide (35 mg/kg and 100 mg, respectively). Blood samples were collected according to the assigned schedule, and the plasma concentration of rebamipide was determined using liquid chromatography-tandem mass spectrometry. A double-peak phenomenon was observed in the PK profile of rebamipide in rats. In contrast, rebamipide showed a conventional PK profile without double peaks in dogs. The half-life of rebamipide in rats (12.85 ± 7.86 h) was longer than that in dogs (5.62 ± 2.24 h), and the apparent total clearance (Clt /F) of rebamipide in rats (3.32 ± 1.18 L/h) was lower than that in dogs (105.01 ± 42.37 L/h). Simple allometric approaches showed that the correlation between body weight and Clt /F (R2 = 0.9287) among rats, dogs, and humans appeared satisfactory. This finding will help not only in understanding the pharmacology of rebamipide but also in establishing a strategy for in vivo evaluation of novel rebamipide formulations.

UI MeSH Term Description Entries
D008297 Male Males
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005765 Gastrointestinal Agents Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. Digestants,Gastric Agents,Gastric Drugs,Gastrointestinal Drugs,Agents, Gastric,Agents, Gastrointestinal,Drugs, Gastric,Drugs, Gastrointestinal
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000409 Alanine A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM. Abufène,Alanine, L-Isomer,L-Alanine,Alanine, L Isomer,L Alanine,L-Isomer Alanine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

In-Hwan Baek, and Dong Kyoung Ha, and Da-Seul Joo, and Min Ji Kim
September 2004, Drug development and industrial pharmacy,
In-Hwan Baek, and Dong Kyoung Ha, and Da-Seul Joo, and Min Ji Kim
October 1995, Zentralblatt fur Veterinarmedizin. Reihe A,
In-Hwan Baek, and Dong Kyoung Ha, and Da-Seul Joo, and Min Ji Kim
June 1994, Journal of biomedical materials research,
In-Hwan Baek, and Dong Kyoung Ha, and Da-Seul Joo, and Min Ji Kim
April 2002, Journal of veterinary pharmacology and therapeutics,
In-Hwan Baek, and Dong Kyoung Ha, and Da-Seul Joo, and Min Ji Kim
January 2022, Frontiers in veterinary science,
In-Hwan Baek, and Dong Kyoung Ha, and Da-Seul Joo, and Min Ji Kim
February 2007, Journal of agricultural and food chemistry,
In-Hwan Baek, and Dong Kyoung Ha, and Da-Seul Joo, and Min Ji Kim
May 1982, Masui. The Japanese journal of anesthesiology,
In-Hwan Baek, and Dong Kyoung Ha, and Da-Seul Joo, and Min Ji Kim
January 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
In-Hwan Baek, and Dong Kyoung Ha, and Da-Seul Joo, and Min Ji Kim
May 2002, Biological & pharmaceutical bulletin,
In-Hwan Baek, and Dong Kyoung Ha, and Da-Seul Joo, and Min Ji Kim
January 2008, Veterinary therapeutics : research in applied veterinary medicine,
Copied contents to your clipboard!